Konkurencja i konsument · 17/04/1996

Hoechst AG Settles Prohibited Trade Practices with Biovail Corporation International

Hoechst AG, a pharmaceutical firm, has agreed to take corrective actions following allegations of unfair trade practices related to its $7.1 billion merger with Marion Merrell Dow, Inc. The company will provide access to toxicology data for a hypertension drug, return confidential information, and refrain from using it, among other requirements.